These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34957507)

  • 21. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
    Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
    J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct loading conditions reveal various patterns of right ventricular adaptation.
    Borgdorff MA; Bartelds B; Dickinson MG; Steendijk P; de Vroomen M; Berger RM
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H354-64. PubMed ID: 23729212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension.
    Mprah R; Ma Y; Adzika GK; Ndzie Noah ML; Adekunle AO; Duah M; Adu-Amankwaah J; Wowui PI; Okwuma JD; Qiao W; Wang C
    Clin Exp Pharmacol Physiol; 2022 May; 49(5):558-566. PubMed ID: 35133684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats.
    Wang D; Li H; Weir EK; Xu Y; Xu D; Chen Y
    Int J Cardiol; 2019 Nov; 295():14-20. PubMed ID: 31402164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
    Wu J; Liu T; Shi S; Fan Z; Hiram R; Xiong F; Cui B; Su X; Chang R; Zhang W; Yan M; Tang Y; Huang H; Wu G; Huang C
    Cardiovasc Diabetol; 2022 Sep; 21(1):197. PubMed ID: 36171554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
    Chen S; Sun P; Li Y; Shen W; Wang C; Zhao P; Cui H; Xue JY; Du GQ
    Eur J Pharmacol; 2022 Oct; 933():175262. PubMed ID: 36100129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blueberry extract improves redox balance and functional parameters in the right ventricle from rats with pulmonary arterial hypertension.
    Türck P; Salvador IS; Campos-Carraro C; Ortiz V; Bahr A; Andrades M; Belló-Klein A; da Rosa Araujo AS
    Eur J Nutr; 2022 Feb; 61(1):373-386. PubMed ID: 34374852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
    Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
    Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.